Strides Pharma Science
Strides Pharma Science Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Strides Pharma Science
Start SIPStrides Pharma Science Investment Rating
-
Master Rating:
-
Strides Pharma Science has an operating revenue of Rs. 3,568.03 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of -18% needs improvement, ROE of -19% is poor and needs improvement. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 387 | 481 | 423 | 456 |
| Operating Expenses Qtr Cr | 341 | 487 | 484 | 438 |
| Operating Profit Qtr Cr | 46 | -6 | -61 | 18 |
| Depreciation Qtr Cr | 22 | 24 | 24 | 24 |
| Interest Qtr Cr | 35 | 35 | 26 | 22 |
| Tax Qtr Cr | 5 | -40 | -38 | -144 |
| Net Profit Qtr Cr | 13 | -4 | -66 | 201 |
Strides Pharma Science Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- 316.3
- 50 Day
- 329.73
- 100 Day
- 333.66
- 200 Day
- 352.72
- 20 Day
- 319.27
- 50 Day
- 342.13
- 100 Day
- 330.92
- 200 Day
- 329.14
Strides Pharma Science Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 302.97 |
| Second Resistance | 306.24 |
| Third Resistance | 311.17 |
| RSI | 38.28 |
| MFI | 25.38 |
| MACD Single Line | -11.83 |
| MACD | -13.51 |
| Support | |
|---|---|
| First Resistance | 294.77 |
| Second Resistance | 289.84 |
| Third Resistance | 286.57 |
Strides Pharma Science Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 171,084 | 5,363,483 | 31.35 |
| Week | 521,549 | 20,444,721 | 39.2 |
| 1 Month | 397,915 | 14,157,812 | 35.58 |
| 6 Month | 509,977 | 19,384,211 | 38.01 |
Strides Pharma Science Result Highlights
Strides Pharma Science Synopsis
NSE-Medical-Generic Drugs
Strides Pharma Scien is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1979.00 Cr. and Equity Capital is Rs. 89.79 Cr. for the Year ended 31/03/2022. Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062.| Market Cap | 2,727 |
| Sales | 1,747 |
| Shares in Float | 6.23 |
| No of funds | 116 |
| Yield | 0.36 |
| Book Value | 0.8 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | 4 |
| Alpha | -0.08 |
| Beta | 1.33 |
Strides Pharma Science
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 30.89% | 31.07% | 30.37% | |
| Mutual Funds | 11.65% | 8.32% | 9.81% | |
| Insurance Companies | 5.26% | 5.26% | ||
| Foreign Portfolio Investors | 18.98% | 21.43% | 21.21% | |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | |
| Individual Investors | 22.43% | 22.4% | 22.29% | |
| Others | 10.78% | 11.51% | 16.31% |
Strides Pharma Science Management
| Name | Designation |
|---|---|
| Mr. Arun Kumar | Exe.Chairman & Mng.Director |
| Mr. Badree Komandur | Executive Director & Group CFO |
| Mr. Deepak Vaidya | Non Executive Director |
| Dr. Kausalya Santhanam | Independent Director |
| Mr. Bharat D Shah | Independent Director |
| Mr. Homi Rustam Khusrokhan | Independent Director |
| Mr. S Sridhar | Independent Director |
Strides Pharma Science Forecast
Price Estimates
Strides Pharma Science FAQs
What is Share Price of Strides Pharma Science ?
Strides Pharma Science share price is ₹302 As on 08 February, 2023 | 08:06
What is the Market Cap of Strides Pharma Science ?
The Market Cap of Strides Pharma Science is ₹2727.1 Cr As on 08 February, 2023 | 08:06
What is the P/E ratio of Strides Pharma Science ?
The P/E ratio of Strides Pharma Science is -16.6 As on 08 February, 2023 | 08:06
What is the PB ratio of Strides Pharma Science ?
The PB ratio of Strides Pharma Science is 1.1 As on 08 February, 2023 | 08:06